Skip to Main Content

Paper Details

Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.
Oncologist
22
2020
APC, AR, AR gene, AR mutations, Advanced Prostate Cancer, BRAF, CDK6, Circulating Tumor DNA, EGFR, F877L, FGFR1, H875Y, L702H, MET, MYC, PATIENTS, PCa, PIK3CA, Patients, T878A, T878S, TP53, W742C, W742L, abiraterone, advanced PCa, advanced prostate cancer, androgen, androgen receptor gene, bicalutamide, castrate-resistant prostate cancer, circulating, circulating tumor DNA, ctDNA, ctDNA gene, enzalutamide, genes, non, patients, prostate cancer
Author NameAffiliation
Mark YandellUniversity of Utah
Mark YandellUniversity of Utah
Rebecca NagyInc.
Neeraj AgarwalHuntsman Cancer Institute, University of Utah
Oliver SartorTulane Cancer Center
Oliver SartorTulane University School of Medicine
  • 1 - 6

Datasets

Release 1.2